DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Recruiting
1,500 enrolled
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Phase 3 Recruiting
110 enrolled
PARTNER
Recruiting
6,250 enrolled
International PPB/DICER1 Registry
Recruiting
3,400 enrolled
PPB
Completed
1,247 enrolled
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Phase 2 Completed
62 enrolled 15 charts
CLADatabase
Unknown
100 enrolled
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Completed
31 enrolled